| 30.10.2025 07:00 | SAR | Appointment of Joint Corporate Broker | RNS |
| 23.10.2025 15:06 | NWT, IMM, DIS | EARNINGS AND TRADING: Distil narrows loss despite "challenging market" | Alliance |
| 23.10.2025 07:00 | SAR | Preliminary Results for Year Ended 30 June 2025 | RNS |
| 16.10.2025 15:09 | ULVR, SYNT, STJ | UK earnings, trading statements calendar - next 7 days | Alliance |
| 10.10.2025 10:11 | SAR | Sareum falls after safety study halted over animal welfare concerns | Alliance |
| 10.10.2025 10:10 | DKL, SAR, RENX | AIM WINNERS & LOSERS: Sareum halts study over control group issues | Alliance |
| 10.10.2025 07:00 | SAR | Update on toxicology study for SDC-1801 | RNS |
| 07.10.2025 07:00 | SAR | Notice of Results and Investor Presentation | RNS |
| 26.09.2025 15:12 | SAR | Exercise of Warrants | RNS |
| 18.09.2025 12:59 | SAR | Exercise of Warrants | RNS |
| 26.08.2025 07:00 | SAR | Exercise of Warrants | RNS |
| 20.08.2025 10:01 | SAR | Exercise of Warrants | RNS |
| 12.08.2025 16:51 | SAR | Sareum shares climb on partnership with AI-driven drug discovery firm | Alliance |
| 12.08.2025 07:00 | SAR | Sareum Collaboration with Receptor.AI | RNS |
| 09.07.2025 07:00 | SAR | Exercise of Warrants | RNS |
| 04.07.2025 07:00 | SAR | Appointment of Sole Broker | RNS |
| 29.05.2025 07:00 | SAR | Initiation of Toxicology Studies for SDC-1801 | RNS |
| 28.04.2025 07:00 | SAR | Update on TYK2/JAK1 and SRA737 Programmes | RNS |
| 24.04.2025 07:00 | SAR | Exercise of Warrants | RNS |
| 27.03.2025 13:57 | TLW, PANR, FTC | DIRECTOR DEALINGS: Roadside Real Estate chair ups stake toward 26% | Alliance |
| 27.03.2025 07:00 | SAR | Director’s Dealing | RNS |
| 25.03.2025 07:00 | SAR | Sareum Half-Year Report | RNS |
| 20.03.2025 07:00 | SAR | Notice of HY Results and Investor Presentation | RNS |
| 13.03.2025 07:15 | SAR | Institutional Equity Fundraise | RNS |
| 13.03.2025 07:08 | SAR | Sareum Acquires Licence for SRA737 | RNS |
| 31.12.2024 10:58 | SAR, VAL, ROSE | AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank | Alliance |
| 31.12.2024 10:50 | GSK, SAR | Sareum served notice on commercial licence for cancer treatment | Alliance |
| 31.12.2024 07:00 | SAR | Update on SRA737 | RNS |
| 19.12.2024 16:07 | SAR | Results of AGM | RNS |
| 19.12.2024 07:00 | SAR | AGM Statement | RNS |
| 18.12.2024 07:00 | SAR | Appointment of Joint Broker | RNS |
| 16.12.2024 07:00 | SAR | Award of Share Options | RNS |
| 12.12.2024 11:45 | RENX, SAR, PTEC | UK shareholder meetings calendar - next 7 days | Alliance |
| 27.11.2024 09:38 | SAR | Notice of AGM, Annual Report and Accounts | RNS |
| 29.10.2024 14:27 | SAR | Sareum annual loss widens as remains focused on autoimmune diseases | Alliance |
| 29.10.2024 07:00 | SAR | Final Results for the Year Ended 30 June 2024 | RNS |
| 23.10.2024 07:00 | SAR | Notice of Final Results and Investor Presentation | RNS |
| 21.10.2024 18:21 | SAR | IN BRIEF: Sareum raises further GBP1.0 million via subscription | Alliance |
| 11.10.2024 15:53 | SAR | Sareum Holdings completes GBP2.4 million fundraise to boost lead asset | Alliance |
| 11.10.2024 07:00 | SAR | Subscription to raise £2,364,000 | RNS |
| 16.09.2024 14:27 | SAR | Sareum receives patent allowance for crystalline SDC-1801 in China | Alliance |
| 16.09.2024 07:00 | SAR | Patent Allowance in China | RNS |
| 02.09.2024 07:00 | SAR | US patent allowance | RNS |
